Acuta Capital Partners’s Surrozen SRZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.5M Buy
173,395
+548
+0.3% +$15.1K 3.14% 10
2026
Q1
$5.04M Sell
172,847
-5,568
-3% -$133K 3.55% 8
2025
Q4
$4.03M Hold
178,415
2.74% 11
2025
Q3
$2.3M Buy
178,415
+8,415
+5% +$88.2K 2.38% 13
2025
Q2
$1.52M Hold
170,000
2.12% 16
2025
Q1
$1.98M Buy
+170,000
New +$1.98M 2.3% 18

Other funds holding SRZN

Acuta Capital Partners's SRZN Position: Q2 2026 in Review

Acuta Capital Partners increased its Surrozen (SRZN) stake by 0.32% in Q2 2026, buying an estimated $15.1K and bringing the position to 173,395 shares worth $4.5M. The position accounts for 3.14% of the portfolio, ranked #10.

Acuta Capital Partners first reported a position in SRZN in Q1 2025 and has held it in 6 quarters since. The position peaked at $5.04M in Q1 2026. 70 funds tracked by Wall St. Rank hold SRZN as of Q2 2026.

  • Acuta Capital Partners held 173,395 shares of Surrozen worth $4.5M as of Q2 2026.
  • Acuta Capital Partners bought 548 Surrozen shares in Q2 2026, an estimated $15.1K.
  • Surrozen made up 3.14% of Acuta Capital Partners's portfolio in Q2 2026, its #10 holding.
  • Acuta Capital Partners first reported a position in Surrozen in Q1 2025 and has held it in 6 quarters since.
  • Acuta Capital Partners's Surrozen position peaked at $5.04M in Q1 2026.
  • 70 funds tracked by Wall St. Rank held Surrozen as of Q2 2026.

Based on Acuta Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.